Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of RESF1 mRNA | CTD | PMID:21983209 and PMID:24140754 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of RESF1 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RESF1 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RESF1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RESF1 mRNA | CTD | PMID:21215274 and PMID:33387578 | 2-palmitoylglycerol | increases expression | ISO | RESF1 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of RESF1 mRNA | CTD | PMID:37199045 | all-trans-retinoic acid | increases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RESF1 mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RESF1 mRNA | CTD | PMID:20488242 | antirheumatic drug | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of RESF1 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of RESF1 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | RESF1 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to RESF1 mRNA] | CTD | PMID:32406909 | azoxystrobin | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA | CTD | PMID:33854195 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RESF1 mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | multiple interactions | ISO | RESF1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RESF1 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RESF1 mRNA | CTD | PMID:30816183 more ... | caffeine | decreases phosphorylation | ISO | RESF1 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of RESF1 protein | CTD | PMID:35688186 | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of RESF1 mRNA | CTD | PMID:23125180 | chlorpyrifos | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA | CTD | PMID:33854195 | cisplatin | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of RESF1 mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | RESF1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of RESF1 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RESF1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of RESF1 mRNA | CTD | PMID:20971185 | copper(II) sulfate | increases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of RESF1 mRNA | CTD | PMID:19549813 | crocidolite asbestos | decreases expression | ISO | Resf1 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of RESF1 mRNA | CTD | PMID:29279043 | dicrotophos | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of RESF1 mRNA | CTD | PMID:28302478 | doxorubicin | increases expression | ISO | Resf1 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of RESF1 mRNA | CTD | PMID:36227756 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of RESF1 mRNA | CTD | PMID:29391264 | entinostat | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | entinostat results in decreased expression of RESF1 mRNA | CTD | PMID:27188386 | epoxiconazole | decreases expression | ISO | Resf1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of RESF1 mRNA | CTD | PMID:35436446 | formaldehyde | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of RESF1 mRNA | CTD | PMID:20655997 | FR900359 | affects phosphorylation | ISO | RESF1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of RESF1 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | RESF1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RESF1 gene | CTD | PMID:31601247 | geldanamycin | increases expression | ISO | RESF1 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of KIAA1551 mRNA | CTD | PMID:26705709 | glyphosate | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA | CTD | PMID:33854195 | hydrogen cyanide | increases expression | ISO | Resf1 (Mus musculus) | 6480464 | Hydrogen Cyanide results in increased expression of RESF1 mRNA | CTD | PMID:33914522 | imidacloprid | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA | CTD | PMID:33854195 | indometacin | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Indomethacin results in decreased expression of RESF1 mRNA | CTD | PMID:16984733 | nickel atom | increases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Nickel results in increased expression of RESF1 mRNA | CTD | PMID:25583101 | nickel sulfate | increases expression | ISO | RESF1 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of RESF1 mRNA | CTD | PMID:22714537 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RESF1 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of RESF1 mRNA | CTD | PMID:27153767 | potassium cyanide | increases expression | ISO | Resf1 (Mus musculus) | 6480464 | Potassium Cyanide results in increased expression of RESF1 mRNA | CTD | PMID:33914522 | quercetin | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of RESF1 mRNA | CTD | PMID:21632981 | tetrachloromethane | increases expression | ISO | Resf1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of RESF1 mRNA | CTD | PMID:31919559 | thiabendazole | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA | CTD | PMID:33854195 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of RESF1 mRNA | CTD | PMID:34492290 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of RESF1 mRNA | CTD | PMID:33387578 | triptonide | affects expression | ISO | Resf1 (Mus musculus) | 6480464 | triptonide affects the expression of RESF1 mRNA | CTD | PMID:33045310 | tris(2-butoxyethyl) phosphate | affects expression | ISO | RESF1 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of RESF1 mRNA | CTD | PMID:29024780 | urethane | increases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Urethane results in increased expression of RESF1 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | RESF1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RESF1 mRNA | CTD | PMID:25979313 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of RESF1 mRNA | CTD | PMID:29427782 | valproic acid | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of RESF1 mRNA | CTD | PMID:23179753 more ... | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of RESF1 mRNA | CTD | PMID:20566332 | vorinostat | decreases expression | ISO | RESF1 (Homo sapiens) | 6480464 | Vorinostat results in decreased expression of RESF1 mRNA | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
